Comparison of Postoperative Analgesic Consumption of the Erector Spina Plane Block and Serratus Anterior Plane Block

Not Applicable

• Conditions: Thoracic Diseases
• Interventions: Procedure: Erector Spinae Plane block ( Group ı); Procedure: Serratus Anterior Plane block ( Group ıı); Procedure: Control Group (GROUPIII)

• Registration Number: NCT03904082
• Lead Sponsor: TC Erciyes University

Brief Summary

To evaluate the ability of Erector spina Plane block and Serratus Anterior Plane block to decrease postoperative pain and analgesia requirements in patients undergoing thoracotomy.

Detailed Description

Thoracic wall nerve blocks such as Erector spina Plane block and Serratus Anterior Plane block have become popular for preoperative pain control in patients undergoing thoracotomy.

Study Timeline

• Study First Submitted: 2019-03-23
• Status Verified: 2019-04
• Study Start: 2019-04-01
• Study First Submitted QC: 2019-04-03
• Study First Posted: 2019-04-04
• Last Update Submitted: 2019-04-04
• Last Update Posted: 2019-04-08
• Primary Completion: 2020-01-01
• Study Completion: 2020-01-01

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 105

Inclusion Criteria

ASA I- ASA II Patients

Exclusion Criteria

• history of allergy to the study medication
• refusal to participate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Erector spinae plane block group (ESP)	Erector Spinae Plane block ( Group ı)	Single- shot ultrasound (Esaote Mylab30) guided ESP block with 15 ml 0.25% bupivacain (Marcain 0.5%, Astra Zeneca, Turkey) at the T4 vertebral level will performed preoperatively to patients in the ESP group (Group I).
Serratus Anterior Plane Block Group (SAP)	Serratus Anterior Plane block ( Group ıı)	Single- shot ultrasound (Esaote Mylab30 )guided SAP block with 15 ml 0.25% bupivacain (Marcain 0.5%, Astra Zeneca, Turkey) the T4 vertebral level will performed preoperatively to patients in the SAP group( Group II).
Control Group	Control Group (GROUPIII)	The Control group receive no intervetion ( Group III).

Primary Outcome Measures

Name	Time	Method
Verbal analog Pain Scores on rest and movement	48 hours after surgery	A Research assistant, blinded to the group allocation, interviewed patients and collected data at 6 time intervals ( 2, 4, 6, 12, 24, 48. hours) in the 48 hours postoperatively. Patients were asked to rate their pain using verbal analog scale, where 0= no pain and 10= worst pain possible.
opioid consumption	48 hours after surgery	In the recovery room, all patients will given a patient- controlled analgesia device containing morphine 0.5 mg/ml, set to deliver a 1mg bolus dose of morphine with an 15 min lockout time and 6 mg 1 h limit.Total morphine consumption during the 48 hours postoperative period will recorded at 6 time intervals ( 2, 4, 6, 12, 24, 48. hours).

Secondary Outcome Measures

Name	Time	Method
Incidences of adverse effects (like nausea and vomitting)	48 hours after surgery	Incidences of nausea and vomitting during the 48 hours postoperative period will recorded at 6 time intervals (2,4,6,12,24,48. hours)

Trial Locations

Locations (1)

Ayşe Ülgey; 🇹🇷 Kayseri, Talas, Turkey